Qianhai Health Holdings Limited (0911.HK)
HKD 0.21
(0.0%)
HKD 0.21
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 HKD | 75.2% |
| 2022 | -1.25 HKD | -14467.82% |
| 2021 | 0.01 HKD | 122.96% |
| 2020 | -0.04 HKD | -123.69% |
| 2019 | 0.16 HKD | 435.12% |
| 2018 | 0.03 HKD | 41.71% |
| 2017 | 0.02 HKD | 100.57% |
| 2016 | -3.73 HKD | 43.23% |
| 2015 | -6.57 HKD | -1497.87% |
| 2014 | 0.47 HKD | 38.24% |
| 2013 | 0.34 HKD | -47.69% |
| 2012 | 0.65 HKD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.05 HKD | 0.0% |
| 2024 Q1 | 0.05 HKD | -86.89% |
| 2023 Q3 | 0.18 HKD | 127.27% |
| 2023 Q1 | -0.33 HKD | 77.85% |
| 2023 FY | - HKD | 75.2% |
| 2023 Q4 | 0.35 HKD | 94.44% |
| 2023 Q2 | -0.66 HKD | -100.0% |
| 2022 Q4 | -1.49 HKD | -98.67% |
| 2022 Q3 | -0.75 HKD | -725.0% |
| 2022 Q1 | 0.06 HKD | 246.71% |
| 2022 FY | - HKD | -14467.82% |
| 2022 Q2 | 0.12 HKD | 107.25% |
| 2021 Q4 | 0.02 HKD | 101.2% |
| 2021 FY | - HKD | 122.96% |
| 2021 Q1 | -0.01 HKD | 75.82% |
| 2021 Q2 | -0.02 HKD | -99.09% |
| 2021 Q3 | 0.01 HKD | 137.9% |
| 2020 Q1 | 0.02 HKD | -81.45% |
| 2020 Q2 | 0.04 HKD | 100.0% |
| 2020 Q3 | -0.02 HKD | -156.13% |
| 2020 Q4 | -0.05 HKD | -98.69% |
| 2020 FY | - HKD | -123.69% |
| 2019 Q4 | 0.11 HKD | 100.36% |
| 2019 Q2 | 0.05 HKD | 100.0% |
| 2019 Q1 | 0.02 HKD | 214.9% |
| 2019 FY | - HKD | 435.12% |
| 2019 Q3 | 0.05 HKD | 14.85% |
| 2018 FY | - HKD | 41.71% |
| 2018 Q4 | -0.02 HKD | 0.0% |
| 2018 Q3 | -0.02 HKD | -158.43% |
| 2018 Q2 | 0.04 HKD | 0.28% |
| 2018 Q1 | 0.04 HKD | -31.73% |
| 2017 Q1 | 0.05 HKD | 102.29% |
| 2017 FY | - HKD | 100.57% |
| 2017 Q2 | 0.05 HKD | 0.0% |
| 2017 Q4 | 0.05 HKD | 3.17% |
| 2017 Q3 | 0.05 HKD | -5.62% |
| 2016 Q4 | -2.33 HKD | -133.0% |
| 2016 Q3 | -1.00 HKD | -14.94% |
| 2016 Q2 | -0.87 HKD | -11.54% |
| 2016 Q1 | -0.78 HKD | 91.1% |
| 2016 FY | - HKD | 43.23% |
| 2015 Q2 | 4.27 HKD | 0.0% |
| 2015 Q3 | -8.76 HKD | -305.15% |
| 2015 FY | - HKD | -1497.87% |
| 2015 Q1 | 4.27 HKD | 1372.41% |
| 2015 Q4 | -8.76 HKD | 0.0% |
| 2014 Q3 | 0.29 HKD | -87.5% |
| 2014 Q1 | 2.32 HKD | 510.53% |
| 2014 FY | - HKD | 38.24% |
| 2014 Q4 | 0.29 HKD | 0.0% |
| 2014 Q2 | 2.32 HKD | 0.0% |
| 2013 Q2 | 1.34 HKD | 0.0% |
| 2013 Q4 | 0.38 HKD | 0.0% |
| 2013 Q3 | 0.38 HKD | -71.64% |
| 2013 Q1 | 1.34 HKD | 1463.59% |
| 2013 FY | - HKD | -47.69% |
| 2012 FY | - HKD | 0.0% |
| 2012 Q4 | 0.09 HKD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | 109.147% |
| Grand Pharmaceutical Group Limited | 0.54 HKD | 105.759% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 54.399% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | -139.231% |
| Lee's Pharmaceutical Holdings Limited | 0.03 HKD | 209.507% |
| Essex Bio-Technology Limited | 0.49 HKD | 106.347% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | -498.077% |
| PuraPharm Corporation Limited | -0.27 HKD | 88.481% |
| SSY Group Limited | 0.44 HKD | 107.068% |
| JBM (Healthcare) Limited | 0.15 HKD | 120.733% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | 125.917% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 104.574% |